GDM-P-MSCs derived from placenta (chorionic villus) had a reduced angiogenic capacity which was associated with a downregulation in fibroblast growth factor 2 (bFGF) and VEGF [24]. This evidence concerns the gene VEGFA and gestational diabetes.